![2020 ASCO Virtual Direct™ Highlights](http://media-staging.vumedi.com/thumbs/channel_logo/2021/2/9313bddd-217c-4e1a-8307-dea85e67d764.png.200x0_q85.png)
2020 ASCO Virtual Direct™ Highlights
GYN
2020 ASCO Virtual Direct™ Highlights
2020 ASCO on Ovarian Cancer & GTT: Does Olaparib Maintenance Improve Outcomes in Relapsed Ovarian Cancer? Is There a Role for Avelumab in Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy?
FEATURING
Bradley Corr
- 27 views
- August 18, 2020